2012
DOI: 10.1002/chem.201202990
|View full text |Cite
|
Sign up to set email alerts
|

A Cyclometallated Platinum Complex as a Selective Optical Switch for Quadruplex DNA

Abstract: Hits the spot: A cyclometalled platinum(II) complex with a substituted phenanthroline ligand is reported. The complex has high in vitro affinity for quadruplex DNA and upon binding its emission is switched on. The complex can be easily delivered to the cell by using a metallo-cage as a carrier (see illustration). By means of confocal microscopy, it is shown that the complex is released inside the cell, penetrates the nucleus and localises in the nucleoli.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
45
0
2

Year Published

2013
2013
2023
2023

Publication Types

Select...
3
3

Relationship

2
4

Authors

Journals

citations
Cited by 54 publications
(48 citation statements)
references
References 39 publications
1
45
0
2
Order By: Relevance
“…Diverse types of compounds were encapsulated into the organometallic cages including photosensitizers [135], antiproliferative agents [136,137], fluorescent agents [138,139], dendrimers [140,141], and recently enzyme inhibitors [142,143]. For the latter, two different kinds of enzyme inhibitors were encapsulated into the organometallic cages, namely: (1) synthetic nucleoside derivatives such as the FDA-approved anticancer drug used against colorectal cancer Floxuridine, which is an irreversible inhibitor of thymidylate synthase and (2) antiproliferative ruthenium arene complexes from the so-called RAPTA family (see Figure 1 for the chemical structures of these compounds).…”
Section: Organometallic Compounds As Cargo Delivers Of Enzyme Inhibitorsmentioning
confidence: 99%
“…Diverse types of compounds were encapsulated into the organometallic cages including photosensitizers [135], antiproliferative agents [136,137], fluorescent agents [138,139], dendrimers [140,141], and recently enzyme inhibitors [142,143]. For the latter, two different kinds of enzyme inhibitors were encapsulated into the organometallic cages, namely: (1) synthetic nucleoside derivatives such as the FDA-approved anticancer drug used against colorectal cancer Floxuridine, which is an irreversible inhibitor of thymidylate synthase and (2) antiproliferative ruthenium arene complexes from the so-called RAPTA family (see Figure 1 for the chemical structures of these compounds).…”
Section: Organometallic Compounds As Cargo Delivers Of Enzyme Inhibitorsmentioning
confidence: 99%
“…Other platinum complexes have been encapsulated in the cationic [{(pPr i C 6 H 4 Me)Ru} 6 (donq) 3 (tpt) 2 ] 6+ metalla-prism, {2-(pyridin-l-yl) pyridine}Pt(acac) (a), (2-(4-(pyridin-l-yl)phenyl)pyridine}Pt(acac) (b) [22] and {2-phenyl-6-(2-(piperidin-l-yl)ethoxy)-l,10-phenanthroline)PtCl (c) [23] (Figure 4.3). These square-planar complexes are clearly hydrophobic with these large planar aromatic surfaces, and would have been unable to enter cells without help.…”
Section: Complex-in-a-complex Systemsmentioning
confidence: 99%
“…Platinum complexes for encapsulation in the water-soluble metallaprism [((pPr i C 6 H 4 Me)Ru| 6 (donq) 3 (tpt) 2 ] 6+ , (2-(pyridin-l-yl)pyridine)Pt(acac) (a), {2-(4-(pyridin-l-yl)phenyl)pyridine|Pt(acac); (b)[22] and |2-phenyl-6-(2-(piperidin-l-yl)ethoxy)-l,iO-phenanthroline|PtCl (c)[23].…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…and Ccoordinated phenylpyridine ligands, 12 have exhibited considerably stronger interactions with G-quadruplex DNA for possessing an extended p-surface. Though a few small molecules have been studied to specically bind multimeric G-quadruplex structures, 13-18 most square-planar Pt(II) phenanthroline complexes have been discussed to selectively bind monomeric G-quadruplexes rather than multimeric Gquadruplexes.…”
mentioning
confidence: 99%